Lista de obras -

A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

artículo científico publicado en 2002

A perspective on the selection of unrelated donors and cord blood units for transplantation

artículo científico publicado en 2012

A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study

scientific article published on 07 September 2007

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

artículo científico publicado en 2014

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial

artículo científico publicado en 2019

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

artículo científico publicado en 2017

Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience

scientific article published on 01 April 2004

Allogeneic hematopoietic cell transplant for prolymphocytic leukemia ⬇️

artículo científico publicado en 2009

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia

artículo científico publicado en 2012

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood ⬇️

artículo científico publicado el 4 de agosto de 2010

Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia

artículo científico publicado en 2005

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

artículo científico publicado en 2020

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

scientific article published on 27 August 2013

Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease

artículo científico publicado en 2007

Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group report.

artículo científico

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia

artículo científico publicado en 2019

Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial

artículo científico

Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS

artículo científico publicado en 2020

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

artículo científico publicado en 2003

Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies ⬇️

artículo científico publicado el 26 de mayo de 2010

Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolesce

artículo científico publicado en 2017

Cord-Blood Transplantation in Patients with Minimal Residual Disease

artículo científico publicado en 2016

Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation

article

Cyclophosphamide-Based In Vivo T-Cell Depletion for HLA-Haploidentical Transplantation in Fanconi Anemia ⬇️

artículo científico publicado el 27 de julio de 2012

Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation

artículo científico publicado en 2005

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most

artículo científico publicado en 2018

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

artículo científico publicado en 2016

Donor and recipient sex in allogeneic stem cell transplantation: what really matters

artículo científico publicado en 2016

Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders.

artículo científico publicado en 2018

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders

artículo científico publicado en 2012

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning

artículo científico publicado en 2007

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children

scientific article published on 01 March 2002

Final adult height of patients who received hematopoietic cell transplantation in childhood

artículo científico publicado en 2004

Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation

artículo científico publicado en 2008

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2013

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

artículo científico publicado en 2005

HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients

artículo científico publicado en 2018

HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation

artículo científico publicado en 2010

HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Non-Malignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide

artículo científico publicado en 2020

HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category

artículo científico publicado en 2010

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

artículo científico publicado en 2003

Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: An opportunity to revisit the controversy regarding cord blood banking for private use ⬇️

artículo científico publicado el 2 de marzo de 2011

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients

artículo científico publicado en 2003

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation

artículo científico publicado en 2014

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation

artículo científico publicado en 2015

Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia

artículo científico

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

artículo científico publicado en 2008

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201

artículo científico publicado en 2014

Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders

artículo científico publicado en 2007

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation

artículo científico publicado en 2020

KIR Donor Selection: Feasibility in Identifying better Donors

scientific article published on 24 August 2018

Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation

artículo científico publicado en 2015

Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia ⬇️

artículo científico publicado el 7 de junio de 2011

Limits of HLA mismatching in unrelated hematopoietic cell transplantation

scientific article published on 13 July 2004

Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation

artículo científico publicado en 2017

Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis

artículo científico publicado en 2009

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

artículo científico publicado en 2002

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial

artículo científico publicado en 2009

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

artículo científico publicado en 2016

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

scientific article published on 01 November 2019

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia

article

National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants

artículo científico publicado en 2008

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia ⬇️

artículo científico publicado el 20 de abril de 2011

Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children

artículo científico publicado en 2002

Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives

artículo científico publicado en 2002

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

artículo científico publicado en 2014

Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A

article

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy

artículo científico publicado en 2006

Outcome of Pediatric Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation ⬇️

artículo científico publicado el 17 de agosto de 2012

Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission

artículo científico publicado en 2011

Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission

artículo científico publicado en 2015

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors ⬇️

artículo científico publicado el 18 de octubre de 2012

Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation

artículo científico publicado en 2017

Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Cons

artículo científico publicado en 2017

Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children

artículo científico publicado en 2019

Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources

scientific article published on 28 November 2018

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

artículo científico publicado en 2005

Prospective monitoring for alloimmunization in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies

artículo científico publicado en 2009

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

artículo científico publicado en 2006

Reduced toxicity and prompt engraftment after minimal conditioning of a patient with Fanconi anemia undergoing hematopoietic stem cell transplantation from an HLA-matched unrelated donor

artículo científico publicado en 2003

Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.

artículo científico publicado en 2013

Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome ⬇️

artículo científico publicado el 1 de octubre de 2003

Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases

artículo científico publicado en 2002

Response of Steroid-Refractory Acute GVHD to α1-Antitrypsin

artículo científico publicado en 2016

Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia

artículo científico publicado en 2003

Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection

artículo científico publicado en 2013

Safety and Efficacy of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Adults Undergoing Autologous or Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

artículo científico publicado en 2015

Severe combined immunodeficiency (SCID) presenting with neonatal aplastic anemia.

artículo científico publicado en 2015

Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment

scientific article published on April 2009

Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse

artículo científico publicado en 2009

Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen mismatched donors

artículo científico publicado en 2020

Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia.

artículo científico publicado en 2015

Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome

artículo científico publicado en 2010

Success of allogeneic marrow transplantation for children with severe aplastic anaemia ⬇️

artículo científico publicado el 26 de abril de 2012

Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia

artículo científico publicado en 2003

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases

artículo científico publicado en 2018

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

artículo científico publicado en 2015

The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors ⬇️

artículo científico publicado el 6 de junio de 2013

The outcome of allogeneic hematopoietic cell transplantation for children with FMS-like tyrosine kinase 3 internal tandem duplication-positive acute myelogenous leukemia

artículo científico publicado en 2014

Thyroid function following hematopoietic cell transplantation in children: 30 years' experience

artículo científico publicado en 2008

Towards an HIV cure: a global scientific strategy

artículo científico publicado en 2012

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.

scientific article published on 16 January 2014

Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial

artículo científico publicado en 2014

Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

artículo científico publicado en 2016

Lista de obras de

A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

A perspective on the selection of unrelated donors and cord blood units for transplantation

A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience

Allogeneic hematopoietic cell transplant for prolymphocytic leukemia ⬇️

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood ⬇️

Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease

Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group report.

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia

Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial

Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies ⬇️

Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolesce

Cord-Blood Transplantation in Patients with Minimal Residual Disease

Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation

Cyclophosphamide-Based In Vivo T-Cell Depletion for HLA-Haploidentical Transplantation in Fanconi Anemia ⬇️

Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

Donor and recipient sex in allogeneic stem cell transplantation: what really matters

Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders.

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children

Final adult height of patients who received hematopoietic cell transplantation in childhood

Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients

HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation

HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Non-Malignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide

HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: An opportunity to revisit the controversy regarding cord blood banking for private use ⬇️

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation

Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201

Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation

KIR Donor Selection: Feasibility in Identifying better Donors

Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation

Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia ⬇️

Limits of HLA mismatching in unrelated hematopoietic cell transplantation

Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation

Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia

National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia ⬇️

Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children

Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy

Outcome of Pediatric Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation ⬇️

Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission

Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors ⬇️

Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation

Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Cons

Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children

Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

Prospective monitoring for alloimmunization in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.